Medical oncology (Northwood, London, England) (Med Oncol)

Journal PubWeight™ 2257.54‹?›

Top papers

Rank Title Year PubWeight™‹?›
1 Long non-coding RNA MALAT-1 overexpression predicts tumor recurrence of hepatocellular carcinoma after liver transplantation. 2011 3.24
2 High expression of PD-L1 in lung cancer may contribute to poor prognosis and tumor cells immune escape through suppressing tumor infiltrating dendritic cells maturation. 2010 3.06
3 Physical activity and survival after breast cancer diagnosis: meta-analysis of published studies. 2010 2.48
4 Effect of temsirolimus versus interferon-alpha on outcome of patients with advanced renal cell carcinoma of different tumor histologies. 2009 2.05
5 Metformin and cancer: new applications for an old drug. 2011 2.03
6 Treatment resistance of solid tumors: role of hypoxia and anemia. 2001 1.76
7 Comparison of the prognostic values of various inflammation based factors in patients with pancreatic cancer. 2012 1.70
8 Phase II trial of docetaxel (Taxotere) in patients with adenocarcinoma of the upper gastrointestinal tract previously untreated with cytotoxic chemotherapy: the Eastern Cooperative Oncology Group (ECOG) results of protocol E1293. 1996 1.65
9 Pretreatment neutrophil/lymphocyte ratio is superior to platelet/lymphocyte ratio as a predictor of long-term mortality in breast cancer patients. 2013 1.64
10 Prognostic performance of inflammation-based prognostic indices in patients with resectable colorectal liver metastases. 2015 1.64
11 Primary extragastrointestinal stromal tumor of the transverse mesocolon without c-kit mutations but with PDGFRA mutations. 2008 1.62
12 Inhibition of autophagy by 3-MA potentiates cisplatin-induced apoptosis in esophageal squamous cell carcinoma cells. 2009 1.60
13 Controlled multicentre study of the influence of subcutaneous recombinant human erythropoietin on anaemia and transfusion dependency in patients with ovarian carcinoma treated with platinum-based chemotherapy. 1998 1.59
14 Metastatic small cell lung cancer causing biliary obstruction. 1998 1.57
15 The present and the future of breast cancer burden in the Kingdom of Saudi Arabia. 2008 1.56
16 Safety and treatment patterns of angiogenesis inhibitors in patients with metastatic renal cell carcinoma: evidence from US community oncology clinics. 2011 1.55
17 Initial neutrophil lymphocyte ratio is superior to platelet lymphocyte ratio as an adverse prognostic and predictive factor in metastatic colorectal cancer. 2013 1.52
18 Clinical outcome of patients with docetaxel-resistant hormone-refractory prostate cancer treated with second-line cyclophosphamide-based metronomic chemotherapy. 2009 1.52
19 Quality of life, anxiety and depression in Turkish breast cancer patients and in their husbands. 2008 1.51
20 High expression of serum miR-21 and tumor miR-200c associated with poor prognosis in patients with lung cancer. 2011 1.51
21 Prognostic value of oncoprotein expressions in thyroid papillary carcinoma. 2011 1.51
22 Expression of PTEN and mTOR in sacral chordoma and association with poor prognosis. 2014 1.50
23 Analysis of the clinico-hematological relevance of the breakpoint location within M-BCR in chronic myeloid leukemia. 2012 1.50
24 Up-regulation of HOTAIR long non-coding RNA in human gastric adenocarcinoma tissues. 2013 1.48
25 Neutrophil-lymphocyte ratio as a predictor of outcomes for patients with hepatocellular carcinoma undergoing TAE combined with Sorafenib. 2014 1.48
26 miR-497 modulates multidrug resistance of human cancer cell lines by targeting BCL2. 2011 1.48
27 Renal toxicity and osteonecrosis of the jaw in cancer patients treated with bisphosphonates: a long-term retrospective analysis. 2009 1.47
28 The mTOR pathway is associated with the poor prognosis of human hepatocellular carcinoma. 2009 1.46
29 Matrilysin inhibits proliferation and modulates sensitivity of lung cancer cells to FasL-mediated apoptosis. 2008 1.46
30 Protective effect of L-carnitine versus amifostine against cisplatin-induced nephrotoxicity in rats. 2010 1.45
31 Feasibility of sequential use of sunitinib and temsirolimus in advanced renal cell carcinoma. 2009 1.45
32 The CD44+/CD24- phenotype relates to 'triple-negative' state and unfavorable prognosis in breast cancer patients. 2010 1.45
33 Incidence of hypothyroidism after radiotherapy for nasopharyngeal carcinoma. 2007 1.44
34 Posttreatment plasma VEGF levels may be associated with the overall survival of patients with advanced non-small cell lung cancer treated with bevacizumab plus chemotherapy. 2011 1.44
35 8p21.3 deletion suggesting a probable role of TRAIL-R1 and TRAIL-R2 as candidate tumor suppressor genes in the pathogenesis of multiple myeloma. 2013 1.43
36 Hodgkin lymphoma transformation of chronic lymphocytic leukemia: cases report and discussion. 2013 1.42
37 MicroRNA-21 is involved in osteosarcoma cell invasion and migration. 2010 1.42
38 Utility and cost-effectiveness of screening for hepatocellular carcinoma in a resource-limited setting. 2014 1.42
39 Downregulation of miR-195 correlates with lymph node metastasis and poor prognosis in colorectal cancer. 2011 1.42
40 Effects of a microRNA binding site polymorphism in SLC19A1 on methotrexate concentrations in Chinese children with acute lymphoblastic leukemia. 2014 1.41
41 Type 2 diabetes mellitus and prognosis in early stage breast cancer women. 2011 1.40
42 Aprepitant as prophylaxis of chemotherapy-induced nausea and vomiting in anthracyclines and cyclophosphamide-based regimen for adjuvant breast cancer. 2015 1.40
43 Prognostic value of androgen receptor expression in operable triple-negative breast cancer: a retrospective analysis based on a tissue microarray. 2011 1.40
44 Effect of concomitant use of pentoxifylline and alpha-tocopherol with radiotherapy on the clinical outcome of patients with stage IIIB non-small cell lung cancer: a randomized prospective clinical trial. 2006 1.39
45 Tamoxifen induced-thrombocytopenia: it does occur. 2007 1.39
46 Tumor-associated macrophages infiltration is associated with peritumoral lymphangiogenesis and poor prognosis in lung adenocarcinoma. 2010 1.39
47 MicroRNA-9 up-regulation is involved in colorectal cancer metastasis via promoting cell motility. 2011 1.39
48 Clinical significance of microsatellite instability for stage II or III colorectal cancer following adjuvant therapy with doxifluridine. 2010 1.38
49 Methylene tetrahydrofolate reductase (MTHFR) gene polymorphisms in chronic myeloid leukemia: an Egyptian study. 2013 1.37
50 Overexpression of long noncoding RNA PCAT-1 is a novel biomarker of poor prognosis in patients with colorectal cancer. 2013 1.35
Next 50